Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 6, 2011, Pages 1027-1036

  Liu, Liu ^a   Liu, Lin ^a   Zeng, Fei ^a   Wang, Kai ^a   Huang, Jun ^a   Xin, Lin ^a   Zhu, Pei Qian ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Cancer; Malignancy; Meta analysis; Polymorphism; Risk; Vascular endothelial growth factor

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; ETHNICITY; GC RICH SEQUENCE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; STOMACH CANCER; SYSTEMATIC REVIEW; VEGF GENE;

CASE-CONTROL STUDIES; GENOTYPE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959747603     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-010-0966-9     Document Type: Article

References (48)

1. Abdelrahim M, Konduri S, Basha R, Philip PA, Baker CH (2010) Angiogenesis: an update and potential drug approaches (review). Int J Oncol 36:5-18
2. Al-Moundhri MS, Al-Nabhani M, Burney IA, Al-Farsi AA, Al-Bahrani B (2009) Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms - a case-control study in an Omani population. Mol Carcinog 48:1170-1176
3. Amano M, Yoshida S, Kennedy S et al (2008) Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population. Eur J Gynaecol Oncol 29:333-337
4. Balasubramanian SP, Cox A, Cross SS et al (2007) Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 121:1009-1016 (Pubitemid 47101636)
5. Bax L, Ikeda N, Fukui N et al (2009) More than numbers: the power of graphs in meta-analysis. Am J Epidemiol 169:249-255
6. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
7. Bruyere F, Hovens CM, Marson MN et al (2010) VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J Urol 184:1273-1278
8. Cao C, Ying T, Fang JJ, et al. (2010) Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11,263 subjects. Med Oncol
9. Chae YS, Kim JG, Sohn SK et al (2006) Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 71:266-272
10. Chae YS, Kim JG, Sohn SK et al (2008) Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci 23:421-427
11. Dassoulas K, Gazouli M, Rizos S et al (2009) Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 48:563-569
12. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634 (Pubitemid 27387172)
13. Eysenck HJ (1994) Meta-analysis and its problems. BMJ 309:789-792
14. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15-18
15. Garcia-Closas M, Malats N, Real FX et al (2007) Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 3:e29
16. Grover VK, Cole DE, Hamilton DC (2010) Attributing Hardy-Weinberg disequilibrium to population stratification and genetic association in case-control studies. Ann Hum Genet 74:77-87
17. Guan X, Zhao H, Niu J et al (2009) The VEGF-634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterol 9:77
18. Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027 (Pubitemid 46202320)
19. Hofmann G, Langsenlehner U, Renner W et al (2008) Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol 134:591-595 (Pubitemid 351422611)
20. Hsiao PJ, Lu MY, Chiang FY et al (2007) Vascular endothelial growth factor gene polymorphisms in thyroid cancer. J Endocrinol 195:265-270
21. Jacobs EJ, Feigelson HS, Bain EB et al (2006) Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the cancer prevention study II cohort. Breast Cancer Res 8:R22
22. Jain L, Vargo CA, Danesi R et al (2009) The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 8:2496-2508
23. Jin Q, Hemminki K, Enquist K et al (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647-3653 (Pubitemid 40685580)
24. Kataoka N, Cai Q, Wen W et al (2006) Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 15:1148-1152
25. Ke Q, Liang J, Wang LN et al (2008) Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog 47:647-651
26. Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039-2049
27. Kim YH, Kim MA, Park IA et al (2010) VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival. Gynecol Oncol 119:232-236
28. Klug SJ, Ressing M, Koenig J et al (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 10:772-784
29. Kopec JA, Esdaile JM (1990) Bias in case-control studies. A review. J Epidemiol Community Health 44:179-186 (Pubitemid 20327418)
30. Koukourakis MI, Papazoglou D, Giatromanolaki A et al (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293-298 (Pubitemid 39487303)
31. Lee SJ, Lee SY, Jeon HS et al (2005) Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14:571-575 (Pubitemid 40489197)
32. Li R, Zhao Y, Fan W et al (2011) Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population. Int J Cancer 128:166-175
33. Liu L, Zhuang W, Wang C et al (2010) Interleukin-8-251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. Cytokine 50:328-334
34. Loh M, Koh KX, Yeo BH et al (2009) Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 45:2562-2568
35. Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K (2009) The role of angiogenesis in solid tumours: an overview. Eur J Intern Med 20:663-671
36. Maltese P, Canestrari E, Ruzzo A et al (2009) VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis 24:165-170
37. Niu G, Chen X (2010) Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets 11:1000-1017
38. Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606 (Pubitemid 23188190)
39. Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L (2006) Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 35:21-28 (Pubitemid 44485531)
40. Shih T, Lindley C (2006) Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28:1779-1802 (Pubitemid 46038527)
41. Tzanakis N, Gazouli M, Rallis G et al (2006) Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 94:624-630 (Pubitemid 44851925)
42. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232-1235 (Pubitemid 30611801)
43. Welch S, Spithoff K, Rumble RB, Maroun J (2010) Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol 21:1152-1162
44. Xu B, Li JM, Tong N et al (2010a) VEGFA +936C>T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet 198:7-14
45. Xu B, Feng NH, Tong N et al (2010b) VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Med Oncol 27:1031-1036
46. Zhai R, Liu G, Asomaning K et al (2008a) Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis 29:2330-2334
47. Zhai R, Liu G, Zhou W et al (2008b) Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clin Cancer Res 14:612-617
48. Zheng J, Yu X, Jiang L et al (2010) Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G>A polymorphism and cancer risk: a meta-analysis. BMC Cancer 10:522